Amgen, Takeda and Merck push back against article’s conclusions on the waste generated by current vials for infused drugs.
The practice of packaging infused oncology drugs in “oversized,” single-dose vials leads to significant waste, unnecessarily boosting drug company revenues, according to an article published by Memorial Sloan Kettering Cancer Center’s Peter Bach and others in BMJ March 1.
Based on an analysis of the top 20 cancer drugs that are dosed by body size and packaged in single-dose...
The European Medicines Agency recommended against pan-EU marketing authorization of Roche/Sarpeta’s gene therapy Elevidys for the treatment of Duchenne muscular dystrophy as the US reported another death in an Elevidys patient.
Bristol Myers Squibb’s Opdivo and Merck's Welireg also could benefit from the delay in Medicare price negotiation process eligibility.
The Center for Biologics Evaluation and Research saw departures far outnumber new hires in the second and third quarters of FY 2025, before more than 100 people left July 14 after the reduction-in-force was finalized.
